Post-marketing Study to Collect Safety Data in Heart Transplant Patients Receiving Everolimus
NCT00134940
·
clinicaltrials.gov ↗
COMPLETED
Status
100
Enrollment
INDUSTRY
Sponsor class
Conditions
Coronary Heart Disease
Sponsor
Novartis